Allogeneic Umbilical Cord Mesenchymal Stem Cells (UMSC01)
Ever Supreme had a unique stem cell culturing technology from exclusive licensing, and also established a complete platform for cell culturing, optimization, and analytic verification. Currently, several new drug developments related to mesenchymal stem cells are targeting cardiovascular diseases and strokes.
Advantages and International Competitiveness of UMSC01
■ homogenous cell type (IGF1R+ mesenchymal stem cells)
■ serum-free cell culture technology
■ allogeneic cell source is ready for off-the-shelf therapy
■ Unique administrative route